Jane Street Group, LLC Infinity Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$0.49 - $1.2 $20,384 - $49,920	-41,600 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.85 - $2.4 $44,285 - $125,040	-52,100 Reduced 55.6%	41,600 $47,000
Q4 2021 Feb 15, 2022	SELL	$1.86 - $3.36 $169,632 - $306,432	-91,200 Reduced 49.32%	93,700 $211,000
Q3 2021 Nov 16, 2021	BUY	$1.52 - $3.82 $281,048 - $706,318	184,900 New	184,900 $632,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.